ArticleCancer medicine2025

SNAP-Tag-Based Recombinant Photoimmunotherapeutic Agents for the Selective Detection and Killing of Light-Accessible Melanotransferrin-Expressing Melanoma and Triple-Negative Breast Cancer.

Suzanne Hippolite Magagoum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.